甘咨询：2025年前三季度净利润约1.58亿元

Group 1 - Company Gansu Consulting (SZ 000779) reported Q3 performance with revenue of approximately 1.415 billion yuan, an increase of 3.24% year-on-year [1] - The net profit attributable to shareholders was about 158 million yuan, a decrease of 12.54% year-on-year [1] - Basic earnings per share were 0.3393 yuan, down 11.98% year-on-year [1] Group 2 - As of the report, Gansu Consulting's market capitalization is 4.3 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market faces fundraising challenges [2]